English
Back
Download
Log in to access Online Inquiry
Back to the Top
avatar
Jaguar8 commented on a stock · Nov 16, 2024 05:08

NEWS

Perspective Therapeutics to Discuss Data on [212Pb]VMT-α-NET Presented at the 2024 North American Neuroendocrine Tumor Society (NANETS) Multidisciplinary NET Medical Symposium on November 21, 2024
Perspective Therapeutics (NYSE AMERICAN: CATX) announced the upcoming presentation of initial results from their Phase 1/2a trial of [212Pb]VMT-α-NET at the 2024 NANETS Multidisciplinary NET Medical Symposium. The presentation, titled 'Preliminary safety and efficacy data of [212Pb]VMT-α-NET in somatostatin receptor 2 expressing neuroendocrine tumors,' will be delivered by Dr. Richard L. Wahl on November 22, 2024. The company will host a conference call on November 21 to discuss the data, featuring Dr. Wahl and including a Q&A session.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
1
+0
Translate
Report
7676 Views
Comment
Sign in to post a comment
    avatar
    Jaguar8
    Spread kindness and love. Life is short. Don’t let greed eat you.
    8975
    Followers
    54
    Following
    106K
    Visitors
    Follow
    Heat List
    US
    SymbolMini ChartPrice
    TSLA
    Tesla
    -- 222.150
    NVDA
    NVIDIA
    -- 106.980
    PLTR
    Palantir
    -- 76.380
    AAPL
    Apple
    -- 227.480
    MSTR
    Strategy
    -- 239.270
    Reassessing Chinese Assets
    Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.